Hemodialysis System and Accessory
Gainor Medical Europe
FDA Clearance Information
The hemodialysis system by Gainor Medical Europe was cleared through the FDA 510(k) pathway on November 20, 1990. It is classified as a Class 2 medical device.
What It Is
FDA-Cleared Indications
- Use in hemodialysis treatment for patients with renal failure or inadequate kidney function.
- Use with associated hemodialysis equipment and accessories to remove metabolic waste and excess fluid from the blood.
Clinical Applications
- Hemodialysis for patients with end-stage renal disease.
- Renal replacement therapy when the kidneys cannot adequately remove waste, toxins, or excess fluid.
- Maintenance dialysis performed through an established vascular access, such as an arteriovenous fistula, graft, or dialysis catheter.
- Management of fluid and electrolyte balance during prescribed hemodialysis treatment.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The system must be used with compatible dialysis tubing, bloodlines, dialyzers, fluids, and vascular-access equipment specified by the labeling.
- Treatment requires reliable vascular access, such as an arteriovenous fistula, arteriovenous graft, or tunneled dialysis catheter.
- Patient monitoring is required for blood pressure, fluid removal, electrolyte changes, clotting, air embolism, blood loss, and access complications.
- MRI compatibility cannot be assumed for the complete system or its accessories; equipment should be removed from the MRI environment unless the specific component is labeled MR Safe or MR Conditional.
- Contraindications and handling requirements depend on the system configuration, accessories, patient condition, and manufacturer labeling.
Frequently Asked Questions
What are the clinical indications for hemodialysis system?
The hemodialysis system is indicated for patients with end-stage renal disease requiring renal replacement therapy to manage waste and fluid removal.
What outcomes have been reported in clinical studies?
Clinical studies have reported effective maintenance of vascular access and improved toxin removal and fluid balance in patients undergoing hemodialysis.
What complications have been reported?
Safety data indicate complications such as vascular access issues, including stenosis and occlusion, which may necessitate interventions like balloon angioplasty.